At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
ICAD icad
Trading 05-28 15:18:13 EDT
1.58
+0.00
-0.32%
High1.61
Low1.53
Vol71.60K
Open1.61
D1 Closing1.58
Amplitude5.06%
Mkt Cap41.53M
Tradable Cap39.11M
Total Shares26.37M
T/O112.86K
T/O Rate0.29%
Tradable Shares24.83M
P/B--
ROE--
EPS0.00
52wk High--
52wk Low--
P/E--
Dividend--
Div.Yield--
ROA--
3 Top Small-Cap Growth Opportunities in the AI Era
iCAD, Inc. engages in the provision of cancer detection and therapy solutions in the United States. It operates through two segments, Detection and Therapy. The company provides ProFound AI for digital breast tomosynthesis and 2D mammography; PowerLook, a density assessment solution; and ProFound Risk, a breast cancer risk analysis. The company was formerly known as Howtek, Inc. and changed its name to iCAD, Inc. in June 2002. iCAD, Inc. was incorporated in 1984 and is headquartered in Nashua, New Hampshire.